NANAIMO, B.C – Right this moment, Tilray, Inc. (NASDAQ:TLRY), a world pioneer in cannabis manufacturing, analysis, cultivation and distribution, proclaims the growth of its European management staff with the appointment of Arne Wilkens as Vice President, Enterprise Growth, Europe; José Tempero as Medical Affairs Director, Europe; Maike Gerlach as Vice President, Advertising, Europe; and Nadja Frenzel as Vice President, Industrial Improvement, Europe. As well as, Natalie Bucceri joins Tilray’s worldwide staff as Director, International Portfolio Growth.
“Having robust folks on our staff is important to our success and development,” says Sascha Mielcarek, Tilray’s Managing Director of Europe. “We’re thrilled to welcome this group of extremely expert leaders to our staff. Arne, José, Maike, Nadja and Natalie all be a part of Tilray with wide-ranging expertise in regulated industries. We’re assured their appointments will speed up our international development technique and assist strengthen our place in Europe and different worldwide markets.”
The brand new senior appointments will work collaboratively with Tilray’s sturdy staff of specialists throughout the globe to speed up the corporate’s aggressive European and worldwide growth technique. Tilray’s multi-faceted EU Campus in Portugal, which just lately acquired its manufacturing license and Good Manufacturing Practices (GMP) certification, will function the first hub for the cultivation, processing, analysis and distribution of branded Tilray merchandise all through Europe and different worldwide markets.
The latest Tilray management appointments in Europe embrace:
- Arne Wilkens, VP, Enterprise Growth, Europe, brings 14 years of expertise inside the pharmaceutical and biotech industries primarily in enterprise development-related features. In his most up-to-date function, Arne labored at AiCuris Anti-infective Cures GmbH the place he served as Director of Enterprise Improvement and Alliance Administration overseeing all associate actions, market analytics, industrial evaluations and exterior partnerships. Wilkens graduated from Otto-von-Guericke College with a grasp’s diploma in administration.
- José Tempero, Medical Affairs Director, Europe, involves Tilray with 11 years of expertise within the pharmaceutical business bringing experience in medical affairs and market entry. Most just lately, Tempero led the product-based international medical affairs technique at Grünenthal GmbH. Tempero is professionally educated as a pharmacist and holds his Grasp of Science in public well being.
- Maike Gerlach, VP, Advertising, Europe, joins Tilray from Grünenthal GmbH the place she was the Affiliate Director of Integration Advertising liable for managing the worldwide integration of Zomig®, which was acquired from Astra Zeneca. Throughout her time on this function, Gerlach efficiently constructed and executed the model’s international strategic advertising and marketing plan. Gerlach involves Tilray with 17 years of selling expertise within the pharmaceutical business.
- Nadja Frenzel, VP, Industrial Improvement, Europe, additionally involves Tilray from Grünenthal GmbH the place she contributed to the worldwide industrial technique on the International Industrial Management staff and established a brand new, aggressive, industrial mannequin throughout the advertising and marketing, medical, market entry and industrial excellence departments. Frenzel holds a Grasp of Science in well being coverage, economics and administration from Maastricht College within the Netherlands.
Tilray has a pioneering monitor document as an organization dedicated to creating pharmaceutical-grade medical cannabis merchandise accessible to sufferers in want all around the world. Tilray has already efficiently exported inside Europe to the Czech Republic, Germany, the UK, Cyprus and Croatia and out of doors Europe to Argentina, Chile, the USA, South Africa, Australia and New Zealand. Tilray intends to launch extra merchandise in new markets throughout Europe and around the globe because it continues to broaden.
As part of Tilray’s worldwide growth, the corporate has additionally appointed Natalie Bucceri as Director, International Portfolio Growth. Bucceri most just lately served as a part of group technique for Diageo, main tasks to develop and implement short-term funding trade-offs and long-term strategic initiatives. Previous to working at Diageo, Natalie supported the Merck & Co Asia Pacific government staff on core strategic and business-development tasks. Bucceri’s skilled expertise spans Europe, the USA, Asia, Australia and New Zealand. Bucceri will likely be primarily based out of the U.Ok. and can work immediately with the worldwide growth staff, with a right away concentrate on the European market.